KQ

Kelly Qiao

Healthcare Investor at B Capital

Hong Kong

Investor
VC

Invests in

Stages:

Series B

Locations:

China

  • Min Investment:

    $25,000,000.00

  • Max Investment:

    $60,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Life Sciences
Biotechnology
Genetics
Clinical
Drug Discovery
Oncology
Pharmaceuticals
Diagnostics
Venture Capital
Investments
Infectious Diseases
Clinical Trials
Clinical Development
Healthcare
Sequencing
Due Diligence
Molecular Biology
Genomics
Immunology
Lifesciences

Education

Work Experience

BC
B Capital

2021

  • Senior Principal

    2021

MM
MacroLux Medical Technology Co., Ltd.

2024

  • Investor and Observer

    2024

SI
Spectrumedics International

2024

  • Investor and Board

    2024

GB
Grit Biotechnology

2023

  • Investor and Observer

    2023

AS
AlphaLife Sciences

2022

  • Investor and Observer

    2022

P
ProfoundBio

2022

  • Investor and Observer

    2022

BY
Beijing Yuanxin Technology Co., Ltd.

2021

  • Investor

    2021

    Investor

镁
镁信健康

2021

  • Investor

    2021

    Investor

HT
HiFiBiO Therapeutics

2021

  • Investor and Observer

    2021

    Investor

IM
Insilico Medicine

2021

  • Investor and Observer

    2021

    Investor